Drug recall · July 10, 2024
Eszopiclone Tablets recall
Why: Failed Impurities/Degradation Specifications: Related Substances
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Eszopiclone Tablets, USP 1mg CIV, 30-count bottle, Rx only, Mfd. By: Dr. Reddy's Laboratories Limited, Bachupally - 500 090 INDIA, NDC 55111-629-30
- Lots / codes
Lot#: C2302598, Exp 2/29/2025
- Quantity
- 13,752 bottles
- Company
- Dr. Reddy's Laboratories, Inc., Princeton, NJ
- Distribution
- OH, MS
- Initiated
- June 4, 2024 · Voluntary: Firm initiated
- Classified
- July 2, 2024
- Reported
- July 10, 2024
- How notified
- N/A
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Eszopiclone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.